The Potential Impact of the CMS CY2021 Proposed Rules on Spine
Changes proposed in the CMS 2021 Proposed Rules could weigh heavily on the Spine market if enacted.
By Kim Norton | VP of Reimbursement for Simplify Medical
Florida Joint Venture’s Vision for Elevating Musculoskeletal Care
Ascension and HOPCo partner together to develop creative musculoskeletal care platform that could expand
across the US.
By Lisa Mahan | VP, Orthopedics
Spine Market COVID-19 Update
The latest intel suggests the spine market is rebounding more quickly than expected, but certain new market dynamics will persist.
By Julianne Burns | GM, Spine
Biomedical Solutions: An Interview with John Witkowski, President of DSM Biomedical
SmartTRAK discusses the latest advancements in biomedical solutions with DSM President John Witkowski.
By Kim French | GM, OrthoBio
Weathering the COVID-19 Storm in Orthobiologics: An Interview with Steven Sampson, DO
Founder of The Orthohealing Center (Los Angeles, CA) and of The Orthobiologic Institute (TOBI), Steven Sampson, DO discusses the impact of COVID-19 on the Orthopedic and Sports Medicine community in an interview with SmartTRAK.
By Freddy Buntoum | Senior Analyst, Regen Med and Sports Med
OrthoXel: Patient-Focused Orthopedic Trauma Devices
Ireland-based OrthoXel provides novel fracture fixation devices
using evidence-based implant design for the orthopedic trauma
market.
By Tim Jeavons | Director, European Orthopedic Content and Sales
Unique Biomaterials Opportunity: An Interview with Michael Ziebell, President and CEO of trū Shrimp
SmartTRAK discusses a new biomaterials opportunity for medical devices with Michael Ziebell, President and CEO of trū Shrimp.
By Susan Paquette | VP and GM, Wound
Challenges and Opportunities for Wound Care in Assisted Living Facilities
Bluestone Physician Services’ Sarah Keenan, Chief Clinical Officer, and Jessie Waks, Director of Clinical Practice and Education, discuss challenges and opportunities related to wound care in assisted living facilities in an interview with SmartTRAK.
By Susan Paquette | VP and GM, Wound
S&N Hopes to Solidify its Leadership Position in Wound Biologics
S&N plans to shore up its ailing Advanced Wound Bioactives business with the acquisition of Osiris Therapeutics but the deal may be in question as Osiris shareholders challenge the price.
By Susan Paquette | VP and GM, Wound
Growth Amid Debate: Open vs. Robotic Techniques for Inguinal Hernia Repair
SmartTRAK shines a light on issues and trends in robotic surgery and the market for inguinal hernia matrices.
By Doug Devens | Senior Analyst, Biosurgery
Regenerative Medicine: Riding a Wave of Innovation
SmartTRAK highlights trends in regenerative medicine and profiles emerging companies focused on musculoskeletal regenerative therapies.
By Kim French | GM, OrthoBio
INS 2022: Abbott Highlights Opportunities in Neuromodulation
Ryan Lakin, Abbott DVP of R&D, discusses opportunities in neuromodulation in an interview with SmartTRAK at INS 2022.
By Anne Staylor | Executive Editor, SmartTRAK
Cerenovus: Becoming a Key Player in Stroke
Cerenovus Worldwide President Mark Dickinson discusses stroke care, innovation and becoming a key player in the stroke market in an interview with SmartTRAK.
By Anne Staylor | General Manager, Neuro Therapies
Growth Strategies Amid COVID-19: An Interview with Abbott's Keith Boettiger
Keith Boettiger, Vice President, Neuromodulation, Abbott discusses COVID-19 and the Company’s strategies for growth in an interview with SmartTRAK.
By Anne Staylor | General Manager, Neuro Therapies
Stroke Care During an Evolving Pandemic: An Interview with J Mocco, MD, MS
J Mocco, MD, MS discusses how an evolving pandemic is affecting stroke care in an interview with SmartTRAK.
By Anne Staylor | General Manager, Neuro Therapies
A Critical Crossroad for
COVID-19
Krishnan Chakravarthy, MD, PhD discusses the state of the pandemic and its impact on pain medicine in an interview with SmartTRAK.
By Anne Staylor | General Manager, Neuro Therapies
Medtronic Ups its Game with Percept DBS and BrainSense Technology
Mike Daly, VP and GM of Medtronic’s Brain Modulation, discusses the Company’s new Percept DBS System with BrainSense Technology in an interview with SmartTRAK.
By Anne Staylor | General Manager, Neuro Therapies
Insera Therapeutics: Disruptive Digital Design for Stroke Aspiration
To find out more about Insera Therapeutics, the technology and what’s next for the Company, SmartTRAK interviewed CEO Vikram Janardhan and Chief Medical Officer Vallabh Janardhan, MD at the Society of Neurointerventional Surgery (SNIS) Annual Meeting,
By Anne Staylor | General Manager, Neuro Therapies
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services.